Is the elevated breast cancer risk observed in the WHI study an artifact? [1]

Climacteric

Volumn 7, Issue 3, 2004, Pages 319-322

  Kuhl, H ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE ACETATE; PLACEBO;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTIFACT; ATHEROSCLEROSIS; BREAST CANCER; CANCER RISK; FEMALE; HORMONAL THERAPY; HORMONE SUBSTITUTION; HUMAN; ISCHEMIC HEART DISEASE; LACTATION; LETTER; LIPID BLOOD LEVEL; MALE; MENARCHE; OBESITY; ORAL CONTRACEPTION; PARITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SHIFT WORKER; STATISTICAL SIGNIFICANCE;

ARTIFACTS; BREAST NEOPLASMS; CONFOUNDING FACTORS (EPIDEMIOLOGY); ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; NATIONAL INSTITUTES OF HEALTH (U.S.); RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; RISK FACTORS; UNITED STATES; WOMEN'S HEALTH;

EID: 4944265618     PISSN: 13697137     EISSN: None     Source Type: Journal    
DOI: 10.1080/13697130400003337     Document Type: Letter

References (24)

1. The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. The Women's Health Initiative randomized controlled trial. J Am Med Assoc 2004;291:1701-12
2. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies with 52 705 women with breast cancer and 108 411 women without breast cancer. Lancet 1997;350:1047-59
3. Bush TL, Whiteman M, Flaws JA. Hormone replacement therapy and breast cancer: a qualitative review. Obstet Gynecol 2001;98:498-508
4. Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003;362:419-27
5. Cauley JA, Lucas FL, Kuller LH, et al. Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Ann Intern Med 1999;130:270-7
6. Thomas HV, Key TJ, Allen DS, et al. A prospective study of endogenous serum hormone concentrations and breast cancer risk in postmenopausal women on the island of Guernsey. Br J Cancer 1997;76:401-5
7. Toniolo PG, Levitz M, Zeleniuch-Jacquotte A, et al. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst 1995;87:190-7
8. Peethambaram PP, Ingle JN, Suman VJ, et al. Randomized trial of diethylstilbestrol vs. tamoxifen in postmenopausal women with metastatic breast cancer. An updated analysis. Breast Cancer Res Treat 1999;54:117-22
9. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2002;88:321-33
10. Chlebowski RT, Hendrix Langer RD, et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women. J Am Med Assoc 2003;289:3243-53
11. Colditz GA, Hankinson SE, Hunter DJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995;332:1589-93
12. Garland M, Hunter DJ, Colditz GA, et al. Menstrual cycle characteristics and history of ovulatory infertility in relation to breast cancer risk in a large cohort of US women. Am J Epidemiol 1998;147:636-43
13. Hulka BS, Moorman PG. Breast cancer: hormones and other risk factors. Maturitas 2002;42(Suppl 1):95-108
14. Morimoto LM, White E, Chen Z, et al. Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States). Cancer Causes Control 2002;13:741-51
15. Kvale G. Reproductive factors in breast cancer epidemiology. Acta Oncol 1992;31:187-94
16. Adami HO, Adams G, Boyle P, et al. Breast Cancer etiology. Int J Cancer 1990;Suppl 5:22-39
17. Ewertz M, Duffy SW, Adami HO, et al. Age at first birth, parity and risk of breast cancer: a meta-analysis of 8 studies from the Nordic countries. Int J Cancer 1990;46:597-603
18. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50 302 women with breast cancer and 96 973 women without the disease. Lancet 2002;360:187-95
19. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet 1996;347:1713-27
20. Marchbanks PA, McDonald JA, Wilson HG, et al. Oral contraceptives and the risk of breast cancer. N Engl J Med 2002;346:2025-32
21. Chen WY, Colditz GA, Rosner B, et al. Use of postmenopausal hormones, alcohol, and risk for invasive breast cancer. Ann Intern Med 2002;137:798-804
22. Kaye JA, Meier CR, Walker AM, et al. Statin use, hyperlipidaemia, and the risk of breast cancer. Br J Cancer 2002;86:1436-9
23. McTiernan A, Kooperberg C, White E, et al. Recreational physical activity and the risk of breast cancer in postmenopausal women (WHI cohort study). J Am Med Assoc 2003;290:1331-6
24. Schernhammer ES, Laden F, Speizer FE, et al. Rotating night shifts and risk of breast cancer in women participating in the Nurses' Health Study. J Natl Cancer Inst 2001;93:1563-8